• Abdo H., Derkinderen P., Gomes P., Chevalier J., Aubert P., Masson D., Galmiche J. P., Vanden Berghe P., Neunlist M. and Lardeux B. (2010) Enteric glial cells protect neurons from oxidative stress in part via reduced glutathione. FASEB J. 24, 10821094.
  • Angot E., Steiner J. A., Hansen C., Li J. Y. and Brundin P. (2010) Are synucleinopathies prion-like disorders? Lancet Neurol. 9, 11281138.
  • Beach T. G., Adler C. H., Sue L. I. et al. (2009) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 119, 689702.
  • Borghi R., Marchese R., Negro A., Marinelli L., Forloni G., Zaccheo D., Abbruzzese G. and Tabaton M. (2000) Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci. Lett. 287, 6567.
  • Braak H., Del Tredici K., Bratzke H., Hamm-Clement J., Sandmann-Keil D. and Rub U. (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J. Neurol. 249 (Suppl 3), III/1III/5.
  • Braak H., de Vos R. A., Bohl J. and Del Tredici K. (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 396, 6772.
  • Desplats P., Lee H. J., Bae E. J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E. and Lee S. J. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl Acad. Sci. USA 106, 1301013015.
  • El-Agnaf O. M., Salem S. A., Paleologou K. E. et al. (2003) Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J. 17, 19451947.
  • Emmanouilidou E., Melachroinou K., Roumeliotis T., Garbis S. D., Ntzoumi M., Margaritis L. H., Stefanis L. and Vekrellis K. (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal. J. Neurosci. 30, 68386851.
  • Emmanouilidou E., Elenis D., Papasilekas T., Stranjalis G., Gerozissis K., Ioannou P. C. and Vekrellis K. (2011) Assessment of alpha-synuclein secretion in mouse and human brain parenchyma. PLoS ONE 6, e22225.
  • Fortin D. L., Nemani V. M., Voglmaier S. M., Anthony M. D., Ryan T. A. and Edwards R. H. (2005) Neural activity controls the synaptic accumulation of alpha-synuclein. J. Neurosci. 25, 1091310921.
  • Hansen C., Angot E., Bergström A. L. et al. (2011) Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultures human cells. J. Clin. Invest. 121, 715725.
  • Lee S. J. (2008) Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease. J. Mol. Neurosci. 34, 1722.
  • Lee H. J., Patel S. and Lee S. J. (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J. Neurosci. 25, 60166024.
  • Paillusson S., Tasselli M., Lebouvier T., Mahe M. M., Chevalier J., Biraud M., Cario-Toumaniantz C., Neunlist M. and Derkinderen P. (2010) alpha-Synuclein expression is induced by depolarization and cyclic AMP in enteric neurons. J. Neurochem. 115, 694706.
  • Phillips R. J., Walter G. C., Wilder S. L., Baronowsky E. A. and Powley T. L. (2008) Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease? Neuroscience 153, 733750.
  • Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 20452047.
  • Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. and Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839840.